Biotech

All Articles

Takeda faucets brand new head of US oncology organization-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our summary of significant leadership hirings, shootings ...

Vertex, hammered by AATD once again, goes down 2 assets on dispose of heap

.Tip's attempt to treat an uncommon genetic illness has reached an additional misfortune. The biotec...

Vir increases 3 T-cell engagers from Sanofi, gives up 25% of staff

.Vir Medical's second-quarter earnings record had not been short of big headlines. The business acce...

Galapagos pauses CAR-T cell treatment trial over Parkinsonism scenario

.Galapagos has paused application in a test of a BCMA-directed CAR-T tissue treatment, pushing the b...

James Wilson leaving Penn to release pair of brand-new biotechs

.After greater than thirty years, gene therapy pioneer James Wilson M.D., Ph.D., is leaving behind t...

3 biotechs make an effort to defeat the summer months heat by losing workers

.As biotechs attempt to switch a new webpage in August, at least three providers have shed team in a...

venBio lifts $528M for fifth lifestyle sciences VC fund

.Professional equity capital organization venBio has lifted another half a billion bucks to buy biot...

Otsuka spends $800M for Jnana and its own clinical-stage PKU drug

.Otsuka Pharmaceutical has actually grabbed Boston-based Jnana Therapeutics for $800 million so the ...

FibroGen lays off 75% people team as property fails 2 additional trials

.FibroGen is actually significantly restructuring its own service, giving up 75% of its own united s...

Tracon relax weeks after injectable PD-L1 inhibitor neglect

.Tracon Pharmaceuticals has chosen to wane functions weeks after an injectable invulnerable checkpoi...